Introduction
CAN-296 is a naturally occurring heat stable complex carbohydrate isolated from the cell wall of the fungus Mucor rouxii. It consists mostly of 1,4-, 3,4-and 4,6-linked, and terminal N-acetylglucosamine residues. We have prevously shown that CAN-296 possesses excellent in-vitro fungicidal activity against a wide spectrum of pathogenic yeasts including azole-resistant isolates of Candida albicans and Candida glabrata. 1 Compared with the azoles and polyene compounds, it has a narrow MIC range, and a rapid onset of fungicidal action (99.9% killing within 60 min). CAN-296 appears to have no cross-resistance with any currently used antifungal agents. 1 The mode of action of this novel compound is unknown. In recent years, the role of carbohydrate in biological interactions has increasingly been recognized. 2 Carbohydratebinding receptors, initiating diverse signal transduction pathways, have been described in hepatocytes, 3 alveolar macrophages 4 and other systems. 5 As the yeast cell wall is a dynamic system composed mostly of complex carbohydrates and proteins, we hypothesized that the mechanism of action of CAN-296 may involve interaction of this compound with the fungal cell wall. In this paper, we present data to suggest that CAN-296 binds to fungal cell wall and mediates aggregation of C. albicans. The CAN-296-elicited aggregation of the fungal cells may be the initial step that leads to the potent fungicidal action of this compound. -fold) and triplicate 0.1 mL aliquots were spread on YPD agar (Sigma Chemical Company) plates. The plates were incubated at 35°C for 24 h and the number of cfu/mL of culture was calculated and plotted against different variables. Where applicable, a growth control without CAN-296 was used and compared with the time-kill study as previously described. 1 To determine the effect of various cations on the fungicidal activity of CAN-296, approximately 1 ϫ 10 6 cells of C. albicans 90028 were incubated in 1 mL of YPD broth with the drug (10 mg/L) in the presence of various concentrations (0.312-5 g/L) of CaCl 2 , BaCl 2 , CoCl 4 , CuCl 2 , KCl, LiCl, MgCl 2 and MnCl 3 for 60 min, and the fungicidal activity assay was performed as described above.
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Involvement of calcium inhibitable binding to the cell wall in
Dialysis
One millilitre aliquots of CAN-296 solution (250 mg/L) were incubated in duplicate with CaCl 2 (20 g/L), at 35°C for 60 min. The calcium-treated CAN-296 was then transferred to sterile dialysis bags (Spectrum, Houston, TX, USA) and dialysed against sterile double-distilled water (1 L) at 4°C overnight. The dialysis solution was changed twice. The contents of the dialysis bags were then collected in microfuge tubes and heated to 65°C for 60 min to kill any contaminant microorganisms. The CAN-296 solution was allowed to cool to room temperature and used in the fungicidal activity assays as described above. Dialysed Ca 2ϩ -untreated CAN-296 and Ca 2ϩ -treated but undialysed CAN-296 were used as controls. 
Preparation of cell-wall fragments
C. albicans 90028 cells were grown for 18 h in 1 L YPD broth at 35°C, collected by centrifugation (5000g for 1 min at 4°C) and washed twice with 30 mM Tris buffer (pH 7.0). The resulting pellet was stored at Ϫ20°C. The frozen pellet (approximately 2 g wet weight) was transferred to a mortar and ground to a fine powder with a pestle in dry ice with 0.5 g glass beads/g wet weight of the cell pellet. The ground cells were resuspended in 10 mL of 30 mM Tris buffer (pH 7.0) and centrifuged at 500g for 10 min at 4°C to remove intact cells, glass beads and other heavy particulate matter. Microscopic examination of the supernatant showed р10% intact cells. The clarified supernatant was centrifuged at 17,500g for 30 min at 4°C to sediment the broken cells and cell-wall fragments. The resulting pellet was resuspended in 30 mM Tris buffer (pH 7.0), washed twice with 30 mM Tris buffer (pH 7.0), resuspended in 6 mL of 30 mM Tris buffer (pH 7.0) and used immediately for [ 3 H]CAN-296 binding studies. (St Louis, MO, USA). C. albicans 90028 cells were collected, and washed with and resuspended in YPD broth at a cell density of 2 ϫ 10 7 cells/mL. Five mL aliquots of the cell suspension were incubated in duplicate with CAN-296 5 mg/L (specific activity 1.0 Ci/g CAN-296) at room temperature for 60 min and 0.5 mL aliquots were removed at various intervals. The cells were collected by centrifugation for 1 min in a microcentrifuge, and washed three times rapidly by centrifugation with 30 mM Tris buffer (pH 7.0). The washed cell pellet was resuspended in 0.1 mL of 30 mM Tris buffer (pH 7.0) and the radioactivity associated with the cells was determined by scintillation counting with 5 mL Aquasol (NEN Life Science Products, Boston, MA, USA) as the scintillation fluid.
To study the concentration dependence of the uptake/ binding of CAN-296 in C. albicans, 2 ϫ 10 7 cells were incubated in 1 mL YPD broth in duplicate in the presence of [ 3 H]CAN-296 0.312-10 mg/L (specific activity 1.0 Ci/g CAN-296) for 60 min at room temperature. The cells were then collected by centrifugation and washed, and the radioactivity associated with the cells was determined as described above.
The effect of washing with unlabelled CAN-296 on the uptake of [ 3 H]CAN-296 5 mg/L (specific activity 1 Ci/g CAN-296) at room temperature for 120 min. The washing was initiated by the addition of a 150-fold excess of unlabelled CAN-296 at 60 min of incubation. Aliquots (0.5 mL) of the cell suspension were removed at various time intevals before and after the addition of the unlabelled CAN-296 and the radioactivity associated with the cells before and after the addition of unlabelled CAN-296 was determined as described above.
The effect of calcium on the uptake/binding of [ 3 H]CAN-296 to C. albicans cells was studied by incubating 1 ϫ 10 8 cells in 5 mL YPD broth in duplicate containing [ 3 H]CAN-296 5 mg/L (specific activity 1.0 Ci/g CAN-296) at room temperature for 60 min in the presence of calcium chloride at 0-5.5 g/L. Aliquots (0.5 mL) of the cell suspension were removed at 15 min intervals and the radioactivity associated with the cells was determined as described above.
To study the binding of [ 3 H]CAN-296 to the cell-wall fraction of C. albicans, 3 mL cell-wall preparation was incubated in duplicate with [ 3 H]CAN-296 5 mg/L (specific activity 1.0 C i /g CAN-296) for 120 min at room temperature. Aliquots (0.5 ml) were removed at various time intervals and the cell-wall fragments were collected and washed with 30 mM Tris buffer (pH 7.0) by centrifugation. The resulting pellet was resuspended in 0.1 mL Tris buffer and the radioactivity associated with the cell-wall fragments was determined by scintillation counting as described above. To examine the effect of washing with unlabelled CAN-296 on the binding of [ 3 H]CAN-296 to cell-wall fragments, a 150-fold excess of unlabelled CAN-296 was added at 60 min of incubation. Aliquots of the cellwall fraction were removed at various time intervals before and after the addition of the unlabelled CAN-296. The cell-wall fragments were collected, washed with 30 mM Tris buffer (pH 7.0) by centrifugation and radioactivity associated with the cell-wall fragments was determined by scintillation counting.
Results
Inhibition of the antifungal activity of CAN-296 by calcium and other divalent cations
The effect of various cations on the antifungal activity of CAN-296 on C. albicans was examined by the addition of various amounts of the respective metal chlorides to the growth medium along with the addition of an inhibitory concentration of CAN-296 (10 mg/L). As shown in Table I , calcium, magnesium and lithium at concentrations у0.625 g/L inhibited the antifungal activity of CAN-296, and complete inhibition of CAN-296 activity against C. albicans was obtained at 1.25 g/L. Barium, cobalt and manganese inhibited CAN-296 only at a relatively high concentration (2.5 g/L), whereas copper and potassium had no effect on the activity of CAN-296 at the concentrations used. In these experiments, cations were present simultaneously with the CAN-296 throughout the growth period. Cations alone at the indicated concentrations had no significant effect on the growth of C. albicans.
Removal of calcium from pretreated CAN-296 solution by dialysis at 4°C overnight completely restored the antifungal activity of the compound. Calcium-treated and dialysed as well as calcium-untreated but dialysed CAN-296 killed approximately 99% C. albicans cells. In contrast, calcium-treated CAN-296 was inactive (0% kill). The data also suggest that the effect of calcium on CAN-296 is direct and that binding of calcium to CAN-296 is loose enough for calcium to be removed by dialysis.
CAN-296-mediated aggregation of C. albicans
Intact cells of C. albicans were aggregated and formed clumps in the presence of MIC and higher concentrations of CAN-296. Microscopic examination of the intact cells in the presence of CAN-296 at various time intervals revealed that the aggregate formation reached a plateau within 60 min. Addition of calcium (1-5 g/L) completely inhibited the CAN-296-induced aggregation of cells. Figure 2 , the uptake/binding of CAN-296 to intact cells and the cell-wall fraction were very similar. Addition of a 150-fold excess of unlabelled CAN-296 at mid-course of incubation failed to decrease significantly the radiolabelled CAN-296 associated with either the intact cells or with the cell-wall fraction. The lack of displacement of bound radiolabelled CAN-296 with an excess of unlabelled CAN-296 suggests that this agent binds to the intact cells and the cell-wall fraction of C. albicans very tightly.
CAN-296 binding studies
The effect of calcium on the uptake/binding of [ 3 H]CAN-296 to intact C. albicans cells is shown in Table  II . Calcium inhibited the uptake/binding of radiolabelled CAN-296 to C. albicans cells in a concentration-dependent manner with time. At 5.5 g/L, calcium inhibited cell-associated radioactivity by approximately 95% after 60 min of incubation (Table II) .
Discussion
CAN-296 is a naturally occurring, heat stable complex carbohydrate molecule with a molecular mass of approximately 4300 Da. It has excellent in-vitro activity against a wide spectrum of pathogenic yeast including fluconazoleresistant and amphotericin B-resistant isolates. The effect of CAN-296 on fungal cells is rapid, concentration dependent and lethal. Kill-curve experiments revealed that CAN-296 at 10 mg/L killed Ͼ99.9% of C. albicans cells within 60 min and MIC measurements did not differ from minimum lethal concentrations by more than two-fold for all tested Candida species. 1 Because of its relatively large size and the presence of highly charged residues, it is unlikely that this compound would penetrate the cell membrane easily and accumulate inside the cell. Therefore the mode of action of this compound responsible for its antifungal activity may lie in its ability to act on subcellular component(s) or molecules The uptake/binding of CAN-296 by the C. albicans cells was found to be concentration dependent up to 5 mg/L. At 10 mg/L we observed a decline in the uptake/binding, which was reproduced in three independent determinations. This decline is difficult to explain, but it is possibly related to the rapid cell death known to occur within 30 min at this concentration of the drug. We suspect that at 10 mg/L the cells are killed so rapidly that they do not have sufficient time to accumulate maximal amount of the compound.
Although several likely candidates for the CAN-296 target exist (e.g. cell-wall synthesizing enzymes, proton pumping ATPase) for the action of this complex carbohydrate, nothing is known about the mode of action at present. Our results demonstrate that CAN-296 binds to the fungal cell wall, which also contains complex carbohydrates, and the action of CAN-296 may involve carbohydrate recognition and interaction. The importance of carbohydrates in the mediation of biological functions is increasingly appreciated. 2 However, most data in glycobiology pertain to the interactions of proteins with oligosaccharides, and relatively little is known with regard to carbohydrate-carbohydrate interactions. On the other hand, many animal lectins contain carbohydrate-recognition domains (CRDs), 6 which recognize a variety of sugars. The mannose-binding protein, for instance, is a serum lectin that binds to the surface of yeasts and bacteria and mediates an innate immune response. 2, 7 It recognizes and binds to mannose, N-acetylglucosamine and L-fucose with roughly equal affinities. 8 Other lectins, such as the chicken hepatic lectin, exhibit a much higher specificity. 9 This is achieved, in part, by clustering of several CRDs, each with its own sugar binding site. In the case of the macrophage mannose receptor, the Calcium was found to inhibit CAN-296 activity on three different levels, with inhibition of the fungicidal activity, the aggregation and the binding of CAN-296 to the cell wall. We have not investigated in detail the relationship between the aggregation induced by CAN-296 and its fungicidal activity. We observed a difference in the kinetics of the cell kill and of aggregation. Cell death was observed within 15-30 min 1 whereas aggregation reached a plateau only after 60 min, suggesting that CAN-296-induced aggregation of C. albicans may be unrelated to its fungicidal activity and the observed reduction in cfu is substantially due to cell death rather than aggregation of cells.
Many lectins require calcium for binding activity (C-type lectins). At the binding site of these C-type lectins, specific oligosaccharide equatorial hydroxyl groups act as coordination ligands and bind to Ca 2ϩ . Certain antifungal agents, such as the pradimicins, were found to bind specifically to the yeast wall in the presence of calcium. 11 This binding, through the D-mannopyranoside-binding site, is similar to the sugar-specific action of C-type lectins. 12, 13 In contrast to the promotion of pradimicin activity by calcium, the anti-fungal activity of CAN-296 was inhibited by calcium. Nevertheless, the observation that calcium inhibits binding of CAN-296 to the fungal cell wall raises the possibility that, like the pradimicins, CAN-296 may possess a calcium-binding site.
Calcium and magnesium are also known to inhibit a number of aminoglycoside-membrane interactions including those with bacterial, plasma and subcellular membranes. 14, 15 The high-affinity sites for aminoglycosidemembrane interaction were identified as the acidic phospholipids of the membrane, 16, 17 and the binding is due to a charge interaction between these polycationic antibiotics and the anionic head groups of the acidic phospholipids. Not surprisingly, a number of studies have demonstrated that divalent cations can interfere with these reactions and protect against the neurotoxic, nephrotoxic and ototoxic effects of these antibiotics. Similar mechanisms may be operating in the binding of calcium to CAN-296.
In summary, our observations that CAN-296 binds to the cell wall of C. albicans and that this binding can be reversibly inhibited by calcium and other divalent cations suggest that CAN-296 may possess lectin-and calciumbinding sites, and that its mode of action may involve interaction with the cell wall or cell membrane component(s).
